A phase Ib study to evaluate NB 1001 in patients with type 2 diabetes

Trial Profile

A phase Ib study to evaluate NB 1001 in patients with type 2 diabetes

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 12 Oct 2015

At a glance

  • Drugs NB 1001 (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Oct 2015 Status changed from planning to active, no longer recruiting based on a Naia Limited media release.
    • 09 Jan 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top